{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T13:03:54Z","timestamp":1790946234297,"version":"4.1.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,6,24]],"date-time":"2014-06-24T00:00:00Z","timestamp":1403568000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2014,6,24]],"date-time":"2014-06-24T00:00:00Z","timestamp":1403568000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/srep05411","type":"journal-article","created":{"date-parts":[[2014,6,24]],"date-time":"2014-06-24T05:15:07Z","timestamp":1403586907000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":58,"title":["Small molecule inhibitors of HCV replication from Pomegranate"],"prefix":"10.1038","volume":"4","author":[{"given":"B. Uma","family":"Reddy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ranajoy","family":"Mullick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anuj","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Govindarajan","family":"Sudha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narayanaswamy","family":"Srinivasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saumitra","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,6,24]]},"reference":[{"key":"BFsrep05411_CR1","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/S0168-8278(00)80419-5","volume":"32","author":"N Boyer","year":"2000","unstructured":"Boyer, N. & Marcellin, P. Pathogenesis, diagnosis and management of hepatitis C. J. Hepatol. 32, 98\u2013112 (2000).","journal-title":"J. Hepatol."},{"key":"BFsrep05411_CR2","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1038\/nm.3253","volume":"19","author":"SM Horner","year":"2013","unstructured":"Horner, S. M. & Gale, M., Jr Regulation of hepatic innate immunity by hepatitis C virus. Nat. Med. 19, 879\u2013888 (2013).","journal-title":"Nat. Med."},{"key":"BFsrep05411_CR3","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1016\/j.jhep.2011.12.012","volume":"56","author":"J Guedj","year":"2012","unstructured":"Guedj, J., Dahari, H., Pohl, R. T., Ferenci, P. & Perelson, A. S. Understanding silibinin's modes of action against HCV using viral kinetic modeling. J. Hepatol. 56, 1019\u20131024 (2012).","journal-title":"J. Hepatol."},{"key":"BFsrep05411_CR4","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s12263-012-0281-y","volume":"7","author":"A Trecul","year":"2012","unstructured":"Trecul, A., Morceau, F., Dicato, M. & Diederich, M. Dietary compounds as potent inhibitors of signal transducers and activators of transcription (STAT) 3 regulatory network. Genes Nutr. 7, 111\u2013125 (2012).","journal-title":"Genes Nutr."},{"key":"BFsrep05411_CR5","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1002\/hep.22197","volume":"47","author":"Y Nahmias","year":"2008","unstructured":"Nahmias, Y. et al. Apolipoprotein B-dependent hepatitis C virus secretion is inhibited by the grapefruit flavonoid naringenin. Hepatology 47, 1437\u20131445 (2008).","journal-title":"Hepatology"},{"key":"BFsrep05411_CR6","doi-asserted-by":"publisher","first-page":"21165","DOI":"10.1074\/jbc.M109.004945","volume":"284","author":"M Takeshita","year":"2009","unstructured":"Takeshita, M. et al. Proanthocyanidin from blueberry leaves suppresses expression of subgenomic hepatitis C virus RNA. J. Biol. Chem. 284, 21165\u201321176 (2009).","journal-title":"J. Biol. Chem."},{"key":"BFsrep05411_CR7","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.febslet.2009.12.019","volume":"584","author":"K Kim","year":"2010","unstructured":"Kim, K. et al. Curcumin inhibits hepatitis C virus replication via suppressing the Akt-SREBP-1 pathway. FEBS Lett. 584, 707\u2013712 (2010).","journal-title":"FEBS Lett."},{"key":"BFsrep05411_CR8","doi-asserted-by":"crossref","unstructured":"Anggakusuma. et al. Turmeric curcumin inhibits entry of all hepatitis C virus genotypes into human liver cells. Gut. (2013).","DOI":"10.1016\/S0168-8278(13)61163-0"},{"key":"BFsrep05411_CR9","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1002\/hep.24803","volume":"55","author":"N Calland","year":"2012","unstructured":"Calland, N. et al. (-)-Epigallocatechin-3-gallate is a new inhibitor of hepatitis C virus entry. Hepatology 55, 720\u2013729 (2012).","journal-title":"Hepatology"},{"key":"BFsrep05411_CR10","doi-asserted-by":"publisher","first-page":"e54466","DOI":"10.1371\/journal.pone.0054466","volume":"8","author":"YT Lin","year":"2013","unstructured":"Lin, Y. T. et al. Green tea phenolic epicatechins inhibit hepatitis C virus replication via cycloxygenase-2 and attenuate virus- induced inflammation. PLoS One 8, e54466 (2013).","journal-title":"PLoS One"},{"key":"BFsrep05411_CR11","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1002\/hep.23232","volume":"50","author":"O Gonzalez","year":"2009","unstructured":"Gonzalez, O. et al. The heat shock protein inhibitor Quercetin attenuates hepatitis C virus production. Hepatology 50, 1756\u20131764 (2009).","journal-title":"Hepatology"},{"key":"BFsrep05411_CR12","doi-asserted-by":"publisher","first-page":"e81","DOI":"10.1111\/j.1365-2893.2011.01507.x","volume":"19","author":"L Bachmetov","year":"2012","unstructured":"Bachmetov, L. et al. Suppression of hepatitis C virus by the flavonoid quercetin is mediated by inhibition of NS3 protease activity. J. Viral Hepat. 19, e81\u2013e88 (2012).","journal-title":"J. Viral Hepat."},{"key":"BFsrep05411_CR13","first-page":"128","volume":"13","author":"JS Jurenka","year":"2008","unstructured":"Jurenka, J. S. Therapeutic applications of pomegranate (Punica granatum L.): a review. Altern. Med. Rev. 13, 128\u2013144 (2008).","journal-title":"Altern. Med. Rev."},{"key":"BFsrep05411_CR14","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1158\/1940-6207.CAPR-08-0225","volume":"3","author":"LS Adams","year":"2010","unstructured":"Adams, L. S., Zhang, Y., Seeram, N. P., Heber, D. & Chen, S. Pomegranate ellagitannin-derived compounds exhibit antiproliferative and antiaromatase activity in breast cancer cells in vitro. Cancer Prev. Res. (Phila) 3, 108\u2013113 (2010).","journal-title":"Cancer Prev. Res. (Phila)"},{"key":"BFsrep05411_CR15","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/1471-2334-4-41","volume":"4","author":"AR Neurath","year":"2004","unstructured":"Neurath, A. R., Strick, N., Li, Y. Y. & Debnath, A. K. Punica granatum (Pomegrante) juice provides an HIV-1 entry inhibitor and candidate topical microbicide. BMC Infect. Dis. 4, 41 (2004).","journal-title":"BMC Infect. Dis."},{"key":"BFsrep05411_CR16","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1021\/np50069a008","volume":"53","author":"G Nonaka","year":"1990","unstructured":"Nonaka, G. et al. Anti-AIDS agents, 2: Inhibitory effects of tannins on HIV reverse transcriptase and HIV replication in H9 lymphocyte cells. J. Nat. Prod. 53, 587\u2013595 (1990).","journal-title":"J. Nat. Prod."},{"key":"BFsrep05411_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.antiviral.2010.06.014","volume":"88","author":"A Sundararajan","year":"2010","unstructured":"Sundararajan, A. et al. Influenza virus variation in susceptibility to inactivation by pomegranate polyphenols is determined by envelope glycoproteins. Antiviral Res. 88, 1\u20139 (2010).","journal-title":"Antiviral Res."},{"key":"BFsrep05411_CR18","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.phymed.2012.08.012","volume":"20","author":"Y Yang","year":"2012","unstructured":"Yang, Y., Xiu, J., Zhang, L., Qin, C. & Liu, J. Antiviral activity of punicalagin toward human enterovirus 71 in vitro and in vivo. Phytomedicine 20, 67\u201370 (2012).","journal-title":"Phytomedicine"},{"key":"BFsrep05411_CR19","doi-asserted-by":"publisher","first-page":"4581","DOI":"10.1021\/jf000404a","volume":"48","author":"MI Gil","year":"2000","unstructured":"Gil, M. I., Tomas-Barberan, F. A., Hess-Pierce, B., Holcroft, D. M. & Kader, A. A. Antioxidant activity of pomegranate juice and its relationship with phenolic composition and processing. J. Agric. Food Chem. 48, 4581\u20134589 (2000).","journal-title":"J. Agric. Food Chem."},{"key":"BFsrep05411_CR20","doi-asserted-by":"publisher","first-page":"14813","DOI":"10.1073\/pnas.0505870102","volume":"102","author":"A Malik","year":"2005","unstructured":"Malik, A. et al. Pomegranate fruit juice for chemoprevention and chemotherapy of prostate cancer. Proc. Natl. Acad. Sci. USA. 102, 14813\u201314818 (2005).","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"BFsrep05411_CR21","first-page":"363","volume":"40","author":"KC Thresiamma","year":"1996","unstructured":"Thresiamma, K. C. & Kuttan, R. Inhibition of liver fibrosis by ellagic acid. Indian J. Physiol. Pharmacol. 40, 363\u2013366 (1996).","journal-title":"Indian J. Physiol. Pharmacol."},{"key":"BFsrep05411_CR22","doi-asserted-by":"publisher","first-page":"7152","DOI":"10.1074\/jbc.275.10.7152","volume":"275","author":"S Di Marco","year":"2000","unstructured":"Di Marco, S. et al. Inhibition of the hepatitis C virus NS3\/4A protease. The crystal structures of two protease-inhibitor complexes. J. Biol. Chem. 275, 7152\u20137157 (2000).","journal-title":"J. Biol. Chem."},{"key":"BFsrep05411_CR23","unstructured":"Lin, C. (2006). HCV NS3-4A serine protease. In: Tan, S. L. editor. Hepatitis C viruses: Genomes and Molecular Biology. Norfolk (UK): Horizon Bioscience; 2006. Chapter 6. http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK1623\/."},{"key":"BFsrep05411_CR24","doi-asserted-by":"publisher","first-page":"e1002832","DOI":"10.1371\/journal.ppat.1002832","volume":"8","author":"KP Romano","year":"2012","unstructured":"Romano, K. P. et al. The molecular basis of drug resistance against hepatitis C virus NS3\/4A protease inhibitors. PLoS Pathog. 8, e1002832 (2012).","journal-title":"PLoS Pathog."},{"key":"BFsrep05411_CR25","doi-asserted-by":"publisher","first-page":"2829","DOI":"10.1021\/bi035782y","volume":"43","author":"TR Transue","year":"2004","unstructured":"Transue, T. R., Krahn, J. M., Gabel, S. A., DeRose, E. F. & London, R. E. X-ray and NMR characterization of covalent complexes of trypsin, borate and alcohols. Biochemistry. 43, 2829\u20132839 (2004).","journal-title":"Biochemistry."},{"key":"BFsrep05411_CR26","first-page":"536","volume":"247","author":"AG Murzin","year":"1995","unstructured":"Murzin, A. G., Brenner, S. E., Hubbard, T. & Chothia, C. SCOP: a structural classification of proteins database for the investigation of sequences and structures. J. Mol. Biol. 247, 536\u2013540 (1995).","journal-title":"J. Mol. Biol."},{"key":"BFsrep05411_CR27","doi-asserted-by":"publisher","first-page":"2302","DOI":"10.1093\/nar\/gki524","volume":"33","author":"Y Zhang","year":"2005","unstructured":"Zhang, Y. & Skolnick, J. TM-align: a protein structure alignment algorithm based on the TM-score. Nucleic Acids Res. 33, 2302\u20132309 (2005).","journal-title":"Nucleic Acids Res."},{"key":"BFsrep05411_CR28","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1099\/vir.0.18997-0","volume":"84","author":"M Frese","year":"2003","unstructured":"Frese, M. et al. Hepatitis C virus RNA replication is resistant to tumour necrosis factor-alpha. J. Gen. Virol. 84, 1253\u20131259 (2003).","journal-title":"J. Gen. Virol."},{"key":"BFsrep05411_CR29","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1006\/viro.1994.1381","volume":"202","author":"RE Lanford","year":"1994","unstructured":"Lanford, R. E., Sureau, C., Jacob, J. R., White, R. & Fuerst, T. R. Demonstration of in vitro infection of chimpanzee hepatocytes with hepatitis C virus using strand-specific RT\/PCR. Virology 202, 606\u2013614 (1994).","journal-title":"Virology"},{"key":"BFsrep05411_CR30","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/S0166-0934(01)00281-6","volume":"94","author":"JK Craggs","year":"2001","unstructured":"Craggs, J. K., Ball, J. K., Thomson, B. J., Irving, W. L. & Grabowska, A. M. Development of a strand-specific RT-PCR based assay to detect the replicative form of hepatitis C virus RNA. J. Virol. Methods 94, 111\u2013120 (2001).","journal-title":"J. Virol. Methods"},{"key":"BFsrep05411_CR31","first-page":"14","volume":"1","author":"K Kitazato","year":"2007","unstructured":"Kitazato, K., Wang, Y. & Kobayashi, N. Viral infectious disease and natural products with antiviral activity. Drug Discov. Ther. 1, 14\u201322 (2007).","journal-title":"Drug Discov. Ther."},{"key":"BFsrep05411_CR32","doi-asserted-by":"publisher","first-page":"22725","DOI":"10.1074\/jbc.R110.125294","volume":"285","author":"KD Raney","year":"2010","unstructured":"Raney, K. D., Sharma, S. D., Moustafa, I. M. & Cameron, C. E. Hepatitis C virus non structural protein 3 (HCV NS3): a multifunctional antiviral target. J. Biol. Chem. 285, 22725\u201322731 (2010).","journal-title":"J. Biol. Chem."},{"key":"BFsrep05411_CR33","doi-asserted-by":"publisher","first-page":"6106","DOI":"10.1128\/JVI.00377-11","volume":"85","author":"KP Romano","year":"2011","unstructured":"Romano, K. P. et al. Molecular mechanisms of viral and host cell substrate recognition by hepatitis C virus NS3\/4A protease. J. Virol. 85, 6106\u20136116 (2011).","journal-title":"J. Virol."},{"key":"BFsrep05411_CR34","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1021\/np960040+","volume":"59","author":"E Haslam","year":"1996","unstructured":"Haslam, E. Natural polyphenols (vegetable tannins) as drugs: possible modes of action. J. Nat. Prod. 59, 205\u2013215 (1996).","journal-title":"J. Nat. Prod."},{"key":"BFsrep05411_CR35","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.bmc.2006.09.074","volume":"15","author":"X Li","year":"2007","unstructured":"Li, X., Zhang, W., Qiao, X. & Xu, X. Prediction of binding for a kind of non-peptic HCV NS3 serine protease inhibitors from plants by molecular docking and MM-PBSA method. Bioorg. Med. Chem. 15, 220\u2013226 (2007).","journal-title":"Bioorg. Med. Chem."},{"key":"BFsrep05411_CR36","doi-asserted-by":"publisher","first-page":"9725","DOI":"10.1128\/JVI.79.15.9725-9734.2005","volume":"79","author":"G Waris","year":"2005","unstructured":"Waris, G. & Siddiqui, A. Hepatitis C virus stimulates the expression of cyclooxygenase-2 via oxidative stress: role of prostaglandin E2 in RNA replication. J. Virol. 79, 9725\u20139734 (2005).","journal-title":"J. Virol."},{"key":"BFsrep05411_CR37","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1053\/jhep.2003.50380","volume":"38","author":"J Leng","year":"2003","unstructured":"Leng, J., Han, C., Demetris, A. J., Michalopoulos, G. K. & Wu, T. Cyclooxygenase-2 promotes hepatocellular carcinoma cell growth through AKT activation: evidence for AKT inhibition in celecoxib-induced apoptosis. Hepatology 38, 756\u2013768 (2003).","journal-title":"Hepatology"},{"key":"BFsrep05411_CR38","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1099\/vir.0.19771-0","volume":"85","author":"S Cooray","year":"2004","unstructured":"Cooray, S. The pivotal role of phosphotidylinositol 3-kinase-Akt signal transduction in virus survival. J. Gen. Virol. 85, 1065\u20131076 (2004).","journal-title":"J. Gen. Virol."},{"key":"BFsrep05411_CR39","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/1476-9255-5-9","volume":"5","author":"M Shukla","year":"2008","unstructured":"Shukla, M., Gupta, K., Rasheed, Z., Khan, K. A. & Haqqi, T. M. Bioavailable constituents\/metabolites of pomegranate (Punica granatum L) preferentially inhibit COX2 activity ex vivo and IL-1beta-induced PGE2 production in human chondrocytes in vitro. J. Inflamm. (Lond) 5, 9 (2008).","journal-title":"J. Inflamm. (Lond)"},{"key":"BFsrep05411_CR40","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1023\/B:DRUG.0000047101.02178.07","volume":"23","author":"EP Lansky","year":"2005","unstructured":"Lansky, E. P. et al. Possible synergistic prostate cancer suppression by anatomically discrete pomegranate fractions. Invest. New Drugs 23, 11\u201320 (2005).","journal-title":"Invest. New Drugs"},{"key":"BFsrep05411_CR41","doi-asserted-by":"publisher","first-page":"2804","DOI":"10.3892\/or.2013.2757","volume":"30","author":"L Vanella","year":"2013","unstructured":"Vanella, L. et al. Apoptotic markers in a prostate cancer cell line: effect of ellagic acid. Oncol. Rep. 30, 2804\u20132810 (2013).","journal-title":"Oncol. Rep."},{"key":"BFsrep05411_CR42","doi-asserted-by":"publisher","first-page":"3672","DOI":"10.3748\/wjg.14.3672","volume":"14","author":"M Edderkaoui","year":"2008","unstructured":"Edderkaoui, M. et al. Ellagic acid induces apoptosis through inhibition of nuclear factor kappa B in pancreatic cancer cells. World J. Gastroenterol. 14, 3672\u20133680 (2008).","journal-title":"World J. Gastroenterol."},{"key":"BFsrep05411_CR43","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.3109\/10428194.2011.591014","volume":"52","author":"S Mishra","year":"2011","unstructured":"Mishra, S. & Vinayak, M. Anti-carcinogenic action of ellagic acid mediated via modulation of oxidative stress regulated genes in Dalton lymphoma bearing mice. Leuk. Lymphoma 52, 2155\u20132161 (2011).","journal-title":"Leuk. Lymphoma"},{"key":"BFsrep05411_CR44","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1007\/s00394-003-0396-4","volume":"42","author":"B Cerda","year":"2003","unstructured":"Cerda, B., LIorach, R., Ceron, J. J., Espin, J. C. & Tomas- Barberan, F. A. Evaluation of the bioavailability and metabolism in the rat of punicalagin, anantioxidant polyphenol from pomegranate juice. Eur. J. Nutr. 42, 18\u201328 (2003).","journal-title":"Eur. J. Nutr."},{"key":"BFsrep05411_CR45","doi-asserted-by":"publisher","first-page":"3493","DOI":"10.1021\/jf020842c","volume":"51","author":"B Cerda","year":"2003","unstructured":"Cerda, B., Ceron, J. J., Tomas-Barberan, F. A. & Espin, J. C. Repeated oral administration of high doses of the pomegranate ellagitannin punicalagin to rats for 37 days is not toxic. J. Agric. Food Chem. 51, 3493\u20133501 (2003).","journal-title":"J. Agric. Food Chem."},{"key":"BFsrep05411_CR46","doi-asserted-by":"publisher","first-page":"2334","DOI":"10.1038\/nprot.2006.395","volume":"1","author":"T Kato","year":"2006","unstructured":"Kato, T. et al. Cell culture and infection system for hepatitis C virus. Nat. Protoc. 1, 2334\u20132339 (2006).","journal-title":"Nat. Protoc."},{"key":"BFsrep05411_CR47","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1128\/JVI.01890-06","volume":"81","author":"M Yi","year":"2007","unstructured":"Yi, M., Ma, Y., Yates, J. & Lemon, S. M. Compensatory mutations in E1, p7, NS2 and NS3 enhance yields of cell culture-infectious inter genotypic chimeric hepatitis C virus. J. Virol. 81, 629\u2013638 (2007).","journal-title":"J. Virol."},{"key":"BFsrep05411_CR48","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/S0166-0934(02)00255-0","volume":"107","author":"Y Berdichevsky","year":"2003","unstructured":"Berdichevsky, Y. et al. A novel high throughput screening assay for HCV NS3 serine protease inhibitors. J. Virol. Methods 107, 245\u2013255 (2003).","journal-title":"J. Virol. Methods"},{"key":"BFsrep05411_CR49","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/0003-2697(84)90553-0","volume":"143","author":"SS Twining","year":"1984","unstructured":"Twining, S. S. Fluorescein isothiocyanate-labeled casein assay for proteaolytic enzymes. Anal. Biochem. 143, 30\u201334 (1984).","journal-title":"Anal. Biochem."},{"key":"BFsrep05411_CR50","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/S0022-2836(77)80200-3","volume":"112","author":"FC Bernstein","year":"1977","unstructured":"Bernstein, F. C. et al. The Protein Data Bank: a computer- based archival file for macromolecular structures. J. Mol. Biol. 112, 535\u2013542 (1977).","journal-title":"J. Mol. Biol."},{"key":"BFsrep05411_CR51","doi-asserted-by":"publisher","first-page":"2153","DOI":"10.1093\/bioinformatics\/bth214","volume":"20","author":"Z Feng","year":"2004","unstructured":"Feng, Z. et al. Ligand Depot: a data warehouse for ligands bound to macromolecules. Bioinformatics 20, 2153\u20132155 (2004).","journal-title":"Bioinformatics"},{"key":"BFsrep05411_CR52","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1093\/bioinformatics\/15.4.327","volume":"15","author":"V Sobolev","year":"1999","unstructured":"Sobolev, V., Sorokine, A., Prilusky, J., Abola, E. E. & Edelman, M. Automated analysis of interatomic contacts in proteins. Bioinformatics 15, 327\u2013332 (1999).","journal-title":"Bioinformatics"},{"key":"BFsrep05411_CR53","doi-asserted-by":"publisher","first-page":"D129","DOI":"10.1093\/nar\/gkh028","volume":"32","author":"CT Porter","year":"2004","unstructured":"Porter, C. T., Bartlett, G. J. & Thornton, J. M. The Catalytic Site Atlas: a resource of catalytic sites and residues identified in enzymes using structural data. Nucleic Acids Res. 32, D129\u2013133 (2004).","journal-title":"Nucleic Acids Res."},{"key":"BFsrep05411_CR54","doi-asserted-by":"publisher","first-page":"e15939","DOI":"10.1371\/journal.pone.0015939","volume":"6","author":"CY Chen","year":"2011","unstructured":"Chen, C. Y. TCM Database@Taiwan: the world's largest traditional Chinese medicine database for drug screening in silico. PLoS One 6, e15939 (2011).","journal-title":"PLoS One"},{"key":"BFsrep05411_CR55","doi-asserted-by":"publisher","first-page":"2785","DOI":"10.1002\/jcc.21256","volume":"30","author":"GM Morris","year":"2009","unstructured":"Morris, G. M. et al. AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility. J. Comput. Chem. 30, 2785\u20132791 (2009).","journal-title":"J. Comput. Chem."},{"key":"BFsrep05411_CR56","unstructured":"The PyMOL Molecular Graphics System, Version 1.5.0.4 Schrodinger, LLC."},{"key":"BFsrep05411_CR57","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.bbrc.2010.03.035","volume":"394","author":"G Ciofani","year":"2010","unstructured":"Ciofani, G., Danti, S., D'Alessandro, D., Moscato, S. & Menciassi, A. Assessing cytotoxicity of boron nitride nanotubes: Interference with MTT assay. Biochem. Biophys. Res. Commun. 394, 405\u2013411 (2010).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"BFsrep05411_CR58","unstructured":"OECD Guidelines for the testing of chemicals. OECD 423. Acute Oral Toxicity-Acute toxic class method. Organization for Economic Cooperation and Development, Paris (2001)."},{"key":"BFsrep05411_CR59","doi-asserted-by":"crossref","unstructured":"OECD. (2006). Report of the Validation of the Updated Test Guideline 407: Repeat Dose 28-day Oral Toxicity Study in Laboratory Rats. Series on Testing and Assessment No 59, ENV\/JM\/MONO(2006)26.","DOI":"10.1787\/9789264085275-en"},{"key":"BFsrep05411_CR60","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1053\/j.gastro.2012.03.036","volume":"143","author":"S Haid","year":"2012","unstructured":"Haid, S. et al. A plant-derived flavonoid inhibits entry of all HCV genotypes into human hepatocytes. Gastroenterology 143, 213\u2013222 (2012).","journal-title":"Gastroenterology"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep05411.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep05411","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep05411.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,6]],"date-time":"2023-01-06T01:21:40Z","timestamp":1672968100000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep05411"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6,24]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2014,12,17]]}},"alternative-id":["BFsrep05411"],"URL":"https:\/\/doi.org\/10.1038\/srep05411","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.718466046.793506615","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,6,24]]},"assertion":[{"value":"9 January 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5411"}}